Literature DB >> 12421935

The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.

Mercedes Gonzalez1, Sergio A Quezada, Bruce R Blazar, Angela Panoskaltsis-Mortari, Alexander Y Rudensky, Randolph J Noelle.   

Abstract

Graft-vs-host disease (GVHD) remains the most life-threatening complication following the transfer of allogeneic bone marrow into immunocompromised hosts. Transferred alloreactive T cells respond in a complex manner. While massive T cell expansion is observed upon entry into an allogeneic environment, anergy, apoptosis, and repertoire selection are also observed. The study presented here shows that alloreactive T cell expansion and differentiation vs anergy and suppression are dramatically influenced by host conditioning. Using alloreactive CD4(+) and CD8(+) TCR transgenic (Tg) T cells, a novel GVHD model is presented that allows for the visualization of how alloreactive T cells behave when host conditioning is manipulated. Following the transfer of alloreactive CD4(+) and CD8(+) TCR Tg T cells into sublethally irradiated hosts, both Tg T cells populations expand, develop effector function, and cause GVHD. In contrast, when Tg T cells are transferred in non-irradiated hosts, expansion is observed, but there is no development of effector function or disease. Assessment of CD4(+) Tg T cell function following transfer into non-irradiated hosts reveals that these CD4(+) Tg cells are profoundly anergic and have acquired a regulatory function, as manifested in their ability to suppress the expansion of naive TCR Tg T cells in vitro and in vivo as well as the development of GVHD. These findings underscore the decisive effect of the inflammatory environment created by irradiation in determining the ultimate fate and function of alloreactive T cells in vivo

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421935     DOI: 10.4049/jimmunol.169.10.5581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.

Authors:  Jifeng Zhang; Brice E Barefoot; Wenjian Mo; Divino Deoliveira; Jessica Son; Xiuyu Cui; Elizabeth Ramsburg; Benny J Chen
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

2.  Specificity of CD4+CD25+ regulatory T cell function in alloimmunity.

Authors:  Alberto Sánchez-Fueyo; Sigrid Sandner; Antje Habicht; Christophe Mariat; James Kenny; Nicolas Degauque; Xin Xiao Zheng; Terry B Strom; Laurence A Turka; Mohamed H Sayegh
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

3.  Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.

Authors:  Ping Zhang; Jieying Wu; Divino Deoliveira; Nelson J Chao; Benny J Chen
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-15       Impact factor: 5.742

Review 4.  Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease.

Authors:  Raimon Duran-Struuck; Christene A Huang; Katherine Orf; Roderick T Bronson; David H Sachs; Thomas R Spitzer
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

5.  NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

Authors:  Sanja Vodanovic-Jankovic; Parameswaran Hari; Paulette Jacobs; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

6.  A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells.

Authors:  Kathryn W Juchem; Britt E Anderson; Cuiling Zhang; Jennifer M McNiff; Anthony J Demetris; Donna L Farber; Andrew J Caton; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

7.  Lymph Node Stromal Fiber ER-TR7 Modulates CD4+ T Cell Lymph Node Trafficking and Transplant Tolerance.

Authors:  Bryna E Burrell; Kristi J Warren; Yumi Nakayama; Daiki Iwami; C Colin Brinkman; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

8.  Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease.

Authors:  Juyang Kim; Sohye Park; Hyun-A Kim; Daehee Jung; Hyun Ju Kim; Hye-Jeong Choi; Hong Rae Cho; Byungsuk Kwon
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

9.  Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Authors:  Sergio A Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

10.  Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.

Authors:  Juanita Shaffer; Jean Villard; Terry K Means; Stephen Alexander; David Dombkowski; Bimalangshu R Dey; Steven McAfee; Karen K Ballen; Susan Saidman; Frederic I Preffer; David H Sachs; Thomas R Spitzer; Megan Sykes
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.